These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29412436)

  • 1. Implications of ICD-10 for Sarcopenia Clinical Practice and Clinical Trials: Report by the International Conference on Frailty and Sarcopenia Research Task Force.
    Vellas B; Fielding RA; Bens C; Bernabei R; Cawthon PM; Cederholm T; Cruz-Jentoft AJ; Del Signore S; Donahue S; Morley J; Pahor M; Reginster JY; Rodriguez Mañas L; Rolland Y; Roubenoff R; Sinclair A; Cesari M
    J Frailty Aging; 2018; 7(1):2-9. PubMed ID: 29412436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional Intervention in Sarcopenia: Report from the International Conference on Frailty and Sarcopenia Research Task Force.
    Landi F; Sieber C; Fielding RA; Rolland Y; Guralnik J
    J Frailty Aging; 2018; 7(4):247-252. PubMed ID: 30298173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing Drug Trials for Frailty: ICFSR Task Force 2018.
    Pahor M; Kritchevsky SB; Waters DL; Villareal DT; Morley J; Hare JM; Vellas B
    J Frailty Aging; 2018; 7(3):150-154. PubMed ID: 30095144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHARMACOLOGICAL INTERVENTIONS IN FRAILTY AND SARCOPENIA: REPORT BY THE INTERNATIONAL CONFERENCE ON FRAILTY AND SARCOPENIA RESEARCH TASK FORCE.
    Cesari M; Fielding R; Bénichou O; Bernabei R; Bhasin S; Guralnik JM; Jette A; Landi F; Pahor M; Rodriguez-Manas L; Rolland Y; Roubenoff R; Sinclair AJ; Studenski S; Travison T; Vellas B
    J Frailty Aging; 2015; 4(3):114-120. PubMed ID: 26366378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICFSR Task Force Perspective on Biomarkers for Sarcopenia and Frailty.
    Rodriguez-Mañas L; Araujo de Carvalho I; Bhasin S; Bischoff-Ferrari HA; Cesari M; Evans W; Hare JM; Pahor M; Parini A; Rolland Y; Fielding RA; Walston J; Vellas B
    J Frailty Aging; 2020; 9(1):4-8. PubMed ID: 32150207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically Meaningful Change for Physical Performance: Perspectives of the ICFSR Task Force.
    Guralnik J; Bandeen-Roche K; Bhasin SAR; Eremenco S; Landi F; Muscedere J; Perera S; Reginster JY; Woodhouse L; Vellas B
    J Frailty Aging; 2020; 9(1):9-13. PubMed ID: 32150208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia Trials in Specific Diseases: Report by the International Conference on Frailty and Sarcopenia Research Task Force.
    Vellas B; Fielding R; Bhasin S; Cerreta F; Goodpaster B; Guralnik JM; Kritchevsky S; Legrand V; Forkin C; Magaziner J; Morley JE; Rodriguez-Manas L; Roubenoff R; Studenski S; Villareal DT; Cesari M;
    J Frailty Aging; 2016; 5(4):194-200. PubMed ID: 27883164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoporosis in Frail Older Adults: Recommendations for Research from the ICFSR Task Force 2020.
    Rolland Y; Cesari M; Fielding RA; Reginster JY; Vellas B; Cruz-Jentoft AJ
    J Frailty Aging; 2021; 10(2):168-175. PubMed ID: 33575707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in the Development of Drugs for Sarcopenia and Frailty - Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force.
    Cesari M; Bernabei R; Vellas B; Fielding RA; Rooks D; Azzolino D; Mariani J; Oliva AA; Bhasin S; Rolland Y
    J Frailty Aging; 2022; 11(2):135-142. PubMed ID: 35441189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US Task Force recommendations.
    Vellas B; Pahor M; Manini T; Rooks D; Guralnik JM; Morley J; Studenski S; Evans W; Asbrand C; Fariello R; Pereira S; Rolland Y; Abellan van Kan G; Cesari M; Chumlea WC; Fielding R
    J Nutr Health Aging; 2013 Jul; 17(7):612-8. PubMed ID: 23933872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resilience: Biological Basis and Clinical Significance - A Perspective Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force.
    Cesari M; Azzolino D; LeBrasseur NK; Whitson H; Rooks D; Sourdet S; Angioni D; Fielding RA; Vellas B; Rolland Y
    J Frailty Aging; 2022; 11(4):342-347. PubMed ID: 36346720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carla Task Force on Sarcopenia: propositions for clinical trials.
    Abellan van Kan G; André E; Bischoff Ferrari HA; Boirie Y; Onder G; Pahor M; Ritz P; Rolland Y; Sampaio C; Studenski S; Visser M; Vellas B
    J Nutr Health Aging; 2009 Oct; 13(8):700-7. PubMed ID: 19657553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DESIGNING DRUG TRIALS FOR SARCOPENIA IN OLDER ADULTS WITH HIP FRACTURE - A TASK FORCE FROM THE INTERNATIONAL CONFERENCE ONFRAILTY AND SARCOPENIA RESEARCH (ICFSR).
    Vellas B; Fielding R; Miller R; Rolland Y; Bhasin S; Magaziner J; Bischoff-Ferrari H
    J Frailty Aging; 2014; 3(4):199-204. PubMed ID: 26380231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frailty and sarcopenia: From theory to clinical implementation and public health relevance.
    Cesari M; Nobili A; Vitale G
    Eur J Intern Med; 2016 Nov; 35():1-9. PubMed ID: 27491586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: The future of sarcopenia.
    Morley JE; Bauer JM
    Curr Opin Clin Nutr Metab Care; 2019 Jan; 22(1):1-3. PubMed ID: 30431471
    [No Abstract]   [Full Text] [Related]  

  • 16. Supplement: 9th International Conference on Frailty and Sarcopenia Research (ICFSR), Symposia - Conferences - Oral Communications, February 20-22, 2019, Miami - USA.
    J Frailty Aging; 2019; 8(1):S1-S25. PubMed ID: 30734833
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronology of age-related disease definitions: osteoporosis and sarcopenia.
    Bijlsma AY; Meskers CG; Westendorp RG; Maier AB
    Ageing Res Rev; 2012 Apr; 11(2):320-4. PubMed ID: 22306229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Approaches to the Diagnosis of Sarcopenia.
    Edwards MH; Buehring B
    J Clin Densitom; 2015; 18(4):472-7. PubMed ID: 26059568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia.
    Reginster JY; Cooper C; Rizzoli R; Kanis JA; Appelboom G; Bautmans I; Bischoff-Ferrari HA; Boers M; Brandi ML; Bruyère O; Cherubini A; Flamion B; Fielding RA; Gasparik AI; Van Loon L; McCloskey E; Mitlak BH; Pilotto A; Reiter-Niesert S; Rolland Y; Tsouderos Y; Visser M; Cruz-Jentoft AJ
    Aging Clin Exp Res; 2016 Feb; 28(1):47-58. PubMed ID: 26717937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current pharmacotherapies for sarcopenia.
    Hardee JP; Lynch GS
    Expert Opin Pharmacother; 2019 Sep; 20(13):1645-1657. PubMed ID: 31120352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.